These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18373424)

  • 21. Nanotubes in biological applications.
    Mundra RV; Wu X; Sauer J; Dordick JS; Kane RS
    Curr Opin Biotechnol; 2014 Aug; 28():25-32. PubMed ID: 24832071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon nanotubes in cancer therapy: a more precise look at the role of carbon nanotube-polymer interactions.
    Adeli M; Soleyman R; Beiranvand Z; Madani F
    Chem Soc Rev; 2013 Jun; 42(12):5231-56. PubMed ID: 23443245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbon nanotube exploration in cancer cell lines.
    Kesharwani P; Ghanghoria R; Jain NK
    Drug Discov Today; 2012 Sep; 17(17-18):1023-30. PubMed ID: 22579742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting carbon nanotubes against cancer.
    Fabbro C; Ali-Boucetta H; Da Ros T; Kostarelos K; Bianco A; Prato M
    Chem Commun (Camb); 2012 Apr; 48(33):3911-26. PubMed ID: 22428156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxorubicin Encapsulation in Carbon Nanotubes Having Haeckelite or Stone-Wales Defects as Drug Carriers: A Molecular Dynamics Approach.
    Contreras L; Villarroel I; Torres C; Rozas R
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33805628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic carbon nanotubes: a new tool for shepherding mesenchymal stem cells by magnetic fields.
    Vittorio O; Quaranta P; Raffa V; Funel N; Campani D; Pelliccioni S; Longoni B; Mosca F; Pietrabissa A; Cuschieri A
    Nanomedicine (Lond); 2011 Jan; 6(1):43-54. PubMed ID: 21182417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shape effect of carbon nanovectors on angiogenesis.
    Chaudhuri P; Harfouche R; Soni S; Hentschel DM; Sengupta S
    ACS Nano; 2010 Jan; 4(1):574-82. PubMed ID: 20043662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo biocompatibility testing of functionalized carbon nanotubes.
    Ciofani G; Raffa V; Vittorio O; Cuschieri A; Pizzorusso T; Costa M; Bardi G
    Methods Mol Biol; 2010; 625():67-83. PubMed ID: 20422382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell growth inhibition and apoptosis by SDS-solubilized single-walled carbon nanotubes in normal rat kidney epithelial cells.
    Nam CW; Kang SJ; Kang YK; Kwak MK
    Arch Pharm Res; 2011 Apr; 34(4):661-9. PubMed ID: 21544732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbon-based drug delivery carriers for cancer therapy.
    Lim DJ; Sim M; Oh L; Lim K; Park H
    Arch Pharm Res; 2014 Jan; 37(1):43-52. PubMed ID: 24234911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system.
    Men K; Liu W; Li L; Duan X; Wang P; Gou M; Wei X; Gao X; Wang B; Du Y; Huang M; Chen L; Qian Z; Wei Y
    Nanoscale; 2012 Oct; 4(20):6425-33. PubMed ID: 22955255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping the intracellular distribution of carbon nanotubes after targeted delivery to carcinoma cells using confocal Raman imaging as a label-free technique.
    Lamprecht C; Gierlinger N; Heister E; Unterauer B; Plochberger B; Brameshuber M; Hinterdorfer P; Hild S; Ebner A
    J Phys Condens Matter; 2012 Apr; 24(16):164206. PubMed ID: 22466107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SiRNA delivery with functionalized carbon nanotubes.
    Varkouhi AK; Foillard S; Lammers T; Schiffelers RM; Doris E; Hennink WE; Storm G
    Int J Pharm; 2011 Sep; 416(2):419-25. PubMed ID: 21320582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicity of Carbon Nanotubes as Anti-Tumor Drug Carriers.
    Yan H; Xue Z; Xie J; Dong Y; Ma Z; Sun X; Kebebe Borga D; Liu Z; Li J
    Int J Nanomedicine; 2019; 14():10179-10194. PubMed ID: 32021160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validating the anticancer potential of carbon nanotube-based therapeutics through cell line testing.
    Kesharwani P; Mishra V; Jain NK
    Drug Discov Today; 2015 Sep; 20(9):1049-60. PubMed ID: 25997997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naringenin-Functionalized Multi-Walled Carbon Nanotubes: A Potential Approach for Site-Specific Remote-Controlled Anticancer Delivery for the Treatment of Lung Cancer Cells.
    Morais RP; Novais GB; Sangenito LS; Santos ALS; Priefer R; Morsink M; Mendonça MC; Souto EB; Severino P; Cardoso JC
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review on protein functionalized carbon nanotubes.
    Nagaraju K; Reddy R; Reddy N
    J Appl Biomater Funct Mater; 2015 Dec; 13(4):e301-12. PubMed ID: 26660626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticles Incorporating a Fluorescence Turn-on Reporter for Real-Time Drug Release Monitoring, a Chemoenhancer and a Stealth Agent: Poseidon's Trident against Cancer?
    Attri A; Thakur D; Kaur T; Sensale S; Peng Z; Kumar D; Singh RP
    Mol Pharm; 2021 Jan; 18(1):124-147. PubMed ID: 33346663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multifunctional carbon nano-tubes for biomedical applications (CARBIO). A project of the European Marie Curie Network].
    Krämer K; Meye A; Taylor A; Klingeler R; Mönch I; Hampel S; Leonhard A; Büchner B; Kunze D; Unversucht S; Füssel S; Wirth MP
    Urologe A; 2007 Sep; 46(9):1248. PubMed ID: 17671776
    [No Abstract]   [Full Text] [Related]  

  • 40. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy.
    Prakash S; Malhotra M; Shao W; Tomaro-Duchesneau C; Abbasi S
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1340-51. PubMed ID: 21756952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.